Future directions in treatment of brain metastases

Surgical Neurology International

Volumn 4, Issue SUPPL4, 2013, Pages

  Barani, Igor ^a   Larson, David ^b   Berger, Mitchel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain metastases; radiosurgery; review; targeted therapy; treatments; whole brain radiation therapy

Indexed keywords

CORTICOSTEROID; GADOLINIUM TEXAPHYRIN; MEMANTINE; PLACEBO;

ARTICLE; BRAIN INJURY; BRAIN METASTASIS; CANCER PATIENT; COGNITION; COGNITIVE DEFECT; DATA ANALYSIS; DRUG DOSE REDUCTION; HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY; HUMAN; INFORMATION PROCESSING; INFORMATION RETRIEVAL; MEDLINE; NEUROCOGNITIVE INJURY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; RADIOTHERAPY; STEREOTACTIC RADIOSURGERY; WHOLE BRAIN RADIOTHERAPY;

EID: 84877986566     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.111299     Document Type: Article

References (80)

1. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase Iii results of the Rtog 9508 Randomised Trial. Lancet 2004;363:1665-72
2. Antoniou D, Kyprianou K, Stathopoulos GP, Skarleas C, Kolitsi G, Veslemes M, et al. Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer. Oncol Rep 2005;14:733-6
3. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007;68:1388-95
4. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006;295:2483-91
5. Armstrong CL, Corn BW, Ruffer JE, Pruitt AA, Mollman JE, Phillips PC. Radiotherapeutic effects on brain function: Double dissociation of memory systems. Neuropsychiatry Neuropsychol Behav Neurol 2000;13:101-11
6. Armstrong CL, Hunter JV, Ledakis GE, Cohen B, Tallent EM, Goldstein BH, et al. Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings. Neurology 2002;59:40-8
7. Barani IJ, Benedict SH, Lin PS. Neural stem cells: Implications for the conventional radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys 2007;68:324-33
8. Barani IJ, Cuttino LW, Benedict SH, Todor D, Bump EA, Wu Y, et al. Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys 2007;68:978-85
9. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan detroit cancer surveillance system. J Clin Oncol 2004;22:2865-72
10. Belka C, Budach W, Kortmann RD, Bamberg M. Radiation induced cns toxicity: Molecular and cellular mechanisms. Br J Cancer 2001;85:1233-9
11. Bhangoo SS, Linskey ME, Kalkanis SN. Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am 2011;22:97-104
12. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 2006;64:898-903
13. Bhatnagar AK, Kondziolka D, Lunsford LD, Flickinger JC. Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery. Technol Cancer Res Treat 2007;6:153-60
14. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, et al. The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1980;6:1-9
15. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1981;7:1633-8
16. Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, et al. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int J Radiat Oncol Biol Phys 2012;83:303-9
17. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: A randomised controlled trial. Lancet Oncol 2009;10:1037-44
18. Chang WS, Kim HY, Chang JW, Park YG, Chang JH. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: Is stereotactic radiosurgery effective for multiple brain metastases?. J Neurosurg 2010;113 Suppl: 73-8
19. Chen HS, Lipton SA. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: Uncompetitive antagonism. J Physiol 1997;499:27-46
20. Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992;12:4427-36
21. Clinicaltrials.gov, Dexamethasone and supportive care with or without whole-brain radiation therapy in treating patients with non-small cell lung cancer that has spread to the brain and cannot be removed by surgery
22. Coia LR. The role of radiation therapy in the treatment of brain metastases. Int J Radiat Oncol Biol Phys 1992;23:229-38
23. Danysz W, Parsons CG, Karcz-Kubicha M, Schwaier A, Popik P, Wedzony K, et al. GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids 1998;14:235-9
24. Eichler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist 2007;12:884-98
25. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994;28:797-802
26. Gallagher SJ, Thompson JF, Indsto J, Scurr LL, Lett M, Gao BF, et al. P16ink4a expression and absence of activated b-raf are independent predictors of chemosensitivity in melanoma tumors. Neoplasia 2008;10:1231-9
27. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive Partitioning Analysis (Rpa) of Prognostic Factors in Three Radiation Therapy Oncology Group (Rtog) Brain Metastases Trials. Int J Radiat Oncol Biol Phys 1997;37:745-51
28. Gondi V, Tome WA, Mehta MP. Why avoid the hippocampus? A comprehensive review. Radiother Oncol 2010;97:370-6
29. Gutierrez AN, Westerly DC, Tome WA, Jaradat HA, Mackie TR, Bentzen SM, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: A planning study. Int J Radiat Oncol Biol Phys 2007;69:589-97
30. Halasz LM, Weeks JC, Neville BA, Taback N, Punglia RS. Use of stereotactic radiosurgery for brain metastases: A SEER-medicare analysis. Int J Radiat Biol 2011;81:S550-1
31. Harwood AR, Simson WJ. Radiation therapy of cerebral metastases: A randomized prospective clinical trial. Int J Radiat Oncol Biol Phys 1977;2:1091-4
32. Hsu F, Carolan H, Nichol A, Cao F, Nuraney N, Lee R, et al. Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: A feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 2010;76:1480-5
33. Hunter GK, Suh JH, Reuther AM, Vogelbaum MA, Barnett GH, Angelov L, et al. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2012;83:1394-8
34. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010;60:277-300
35. Johnson JD, Young B. Demographics of brain metastasis. Neurosurg Clin N Am 1996;7:337-44
36. Knisely JP, Yamamoto M, Gross CP, Castrucci WA, Jokura H, Chiang VL. Radiosurgery alone for 5 or more brain metastases: Expert opinion survey. J Neurosurg 2010;113 Suppl: 84-9
37. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the Eortc 22952-26001 Study. J Clin Oncol 2011;29:134-41
38. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427-34
39. Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS. The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1981;7:891-5
40. Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin Oncol 2004;31:702-13
41. Lai CS, Boshoff C, Falzon M, Lee SM. Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. Thorax 2006;61:91
42. Lancelot E, Beal MF. Glutamate toxicity in chronic neurodegenerative disease. Prog Brain Res 1998;116:331-47
43. Lassman AB, DeAngelis LM. Brain Metastases. Neurol Clin 2003;21:1-23
44. Li J, Bentzen SM, Renschler M, Mehta MP. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 2007;25:1260-6
45. Lindquist C. Gamma knife surgery for recurrent solitary metastasis of a cerebral hypernephroma: Case report. Neurosurgery 1989;25:802-4
46. Ma L, Petti P, Wang B, Descovich M, Chuang C, Barani IJ, et al. Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg 2011;114:1580-4
47. Mahmood U, Kwok Y, Regine WF, Patchell RA. Whole-brain irradiation for patients with brain metastases: Still the standard of care. Lancet Oncol 2010;11:221-2
48. Marsh JC, Gielda BT, Herskovic AM, Abrams RA. Cognitive sparing during the administration of whole brain radiotherapy and prophylactic cranial irradiation: Current concepts and approaches. J Oncol 2010;2010:198208
49. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients withcns tumors. J Clin Oncol 2006;24:1305-9
50. Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: No ifs, ands, buts, or sensitivity. J Clin Oncol 2003;21:3557-8
51. Monje ML, Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol 2003;16:129-34
52. Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, et al. A randomized phase iii study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (Rtog) 9104. Int J Radiat Oncol Biol Phys 1997;39:571-4
53. Nath SK, Lawson JD, Simpson DR, Vanderspek L, Wang JZ, Alksne JF, et al. Single-isocenter frameless intensity-modulated stereotactic radiosurgery for simultaneous treatment of multiple brain metastases: Clinical experience. Int J Radiat Oncol Biol Phys 2010;78:91-7
54. Nieder C, Andratschke N, Grosu AL, Molls M. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Strahlenther Onkol. 2003;179:16-20
55. Nieder C, Berberich W, Schnabel K. Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol Biol Phys 1997;39:25-30
56. Norden AD, Wen PY, Kesari S. Brain Metastases. Curr Opin Neurol 2005;18:654-61
57. Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebo-controlled trial (MMM 300). Stroke 2002;33:1834-9
58. Orrego F, Villanueva S. The chemical nature of the main central excitatory transmitter: A critical appraisal based upon release studies and synaptic vesicle localization. Neuroscience 1993;56:539-55
59. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500
60. Pellegrini JW, Lipton SA. Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 1993;33:403-7
61. Prokic V, Wiedenmann N, Fels F, Schmucker M, Nieder C, Grosu AL. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: A planning study on treatment concepts. Int J Radiat Oncol Biol Phys 2013;85:264-70
62. Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications. Int J Radiat Oncol Biol Phys 2002;52:333-8
63. Regine WF, Scott C, Murray K, Curran W. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation Vs. Accelerated-hyperfractionated Radiotherapy: An analysis from radiation therapy oncology group study 91-04. Int J Radiat Oncol Biol Phys 2001;51:711-7
64. Riva M, Landonio G, Arena O, Citterio A, Galli C, Ferrante E, et al. Pathophysiology, clinical manifestations and supportive care of metastatic brain cancer. Forum (Genova) 2001;11:4-26
65. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;94:2698-705
66. Serizawa T, Hirai T, Nagano O, Higuchi Y, Matsuda S, Ono J, et al. Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: Analysis of cases meeting the Japanese prospective multi-institute study (Jlgk0901) inclusion criteria. J Neurooncol 2010; 98:163-7
67. Serizawa T, Yamamoto M, Sato Y, Higuchi Y, Nagano O, Kawabe T, et al. Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J Neurosurg 2010;113 Suppl: 48-52
68. Shaw EG, Gaspar LE, Gibbs FA, Lewin AA, Wharam MD, Larson D, et al. Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000;215 Suppl: 1121-8
69. Shrieve DC, Loeffler JS. Human radiation injury. Philadelphia: Wolters Kluwer Health/Lippincott Williams and Wilkins; 2011
70. Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, et al. Efns Guidelines on diagnosis and treatment of brain metastases: Report of an Efns task force. Eur J Neurol 2006;13:674-81
71. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the rtog database. Int J Radiat Oncol Biol Phys 2008;70:510-4
72. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, et al., Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: A multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010;77:655-61
73. Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, et al. Phase Iii trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: Neurocognitive and quality-of-life analysis. J Clin Oncol 2011;29:279-86
74. Sundstrom JT, Minn H, Lertola KK, Nordman E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 1998;30:296-9
75. Tome WA, Bender ET, Gondi V, Mehta MP. In response to The distribution of brain metastases in the perihippocampal region (regarding Gondi et al., Radiother Oncol 2010;95:327-331) by van Kesteren et al. Radiother Oncol 2011;98:284
76. Tosoni A, Ermani M, Brandes AA. The pathogenesis and treatment of brain metastases: A comprehensive review. Crit Rev Oncol Hematol 2004;52:199-215
77. Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Vichare A, et al. International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. Clin Oncol (R Coll Radiol) 2012;24:e81-92
78. Expert Panel on Radiation Oncology-Brain Metastases, Videtic GM, Gaspar LE, Aref AM, Germano IM, Goldsmith BJ, Imperato JP, et al. American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys 2009;75:961-5
79. Wilcock G, Mobius HJ, Stoffler A. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002;17:297-305
80. Yamamoto M, Kawabe T, Barfod BE. How many metastases can be treated with radiosurgery?. Prog Neurol Surg 2012;25:261-72